The Irish Haemophilia Society has urged the HSE to initiate a public tender to source new medicines to cure Hepatitis C.
The organisation’s chief executive Brian O’Mahony said the price being charged by manufacturers in Ireland for the newest HepC medicines was “unsustainably high.”
Manufacturers are charging the HSE between €45,000 and €80,000 for a 12-week course of the new medicines in various combinations, with a cure rate of...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team